Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q1 | -- | -- | -- | -$0.07 | -- |
| 12/31/2025 | Q4 | -- | -- | -- | -$0.06 | -- |
| 09/30/2025 | Q3 | -- | -- | -$0.19 | -$0.11 | -$0.08 |
| 08/13/2025 | Q2 | -- | -- | -$0.06 | -$0.12 | $0.06 |
| 05/15/2025 | Q1 | -- | -- | -$0.14 | -- | -- |
| 12/31/2024 | Q4 | -- | -- | -- | -- | -- |
| 09/30/2024 | Q3 | -- | -- | -$0.24 | -- | -- |
| 08/19/2024 | Q2 | -- | -- | -$0.80 | -- | -- |
| 05/16/2024 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2023 | Q4 | -- | -- | $1.16 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$0.57 | -- | -- |
| 09/27/2023 | Q2 | -- | -- | -$0.79 | -$1.00 | $0.21 |
| 05/16/2023 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -- | -$1.40 | -- |
| 09/30/2022 | Q3 | -- | -- | -- | -$0.80 | -- |
| 09/27/2022 | Q2 | -- | -- | -$1.92 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$1.94 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$2.44 | -- | -- |
| 12/03/2021 | Q3 | -- | -- | -$0.62 | -- | -- |
| 09/22/2021 | Q2 | -- | -- | -$2.26 | -- | -- |
| 06/29/2021 | Q1 | -- | -- | -$3.04 | -- | -- |
| 03/31/2021 | Q4 | -- | -- | -$3.54 | -- | -- |
| 12/11/2020 | Q3 | -- | -- | $0.54 | -- | -- |
| 09/01/2020 | Q2 | -- | -- | -$4.96 | -- | -- |
| 05/29/2020 | Q1 | -- | -- | -$2.98 | -- | -- |
| 03/16/2020 | Q4 | -- | -- | -$7.30 | -- | -- |
| 11/04/2019 | Q3 | -- | -- | -$2.60 | -- | -- |
| 08/29/2019 | Q2 | -- | -- | -$5.12 | -- | -- |
| 04/23/2019 | Q1 | -- | -- | -$3.22 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$4.44 | -- | -- |
| 11/15/2018 | Q3 | -- | -- | -$4.70 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$20.00 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$1.76 | -- | -- |
| 03/21/2018 | Q4 | -- | -- | -$20.00 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$20.00 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$0.54 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$20.00 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$18.32 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$0.72 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$10.96 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$5.69 | -- | -- |
Akari Therapeutics Plc reported -- worth of top line sales in its most recent quarter.
Akari Therapeutics Plc announced earnings per share of -$0.19 which represents a miss of analyst forecast a -$0.11 per share.
Akari Therapeutics Plc reported -- that represents -- per share over the last quarter.
Akari Therapeutics Plc's earnings are forecast to decrease from -$1.66 per share to -$0.33 per share next year representing a decrease of -80.09%.
Currently, Akari Therapeutics Plc has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on April 8, 2026.
Signup to receive the latest stock alerts
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $3.9T
P/E Ratio: 36x
Market Cap: $3.8T
P/E Ratio: 39x
Regencell Bioscience Holdings Ltd. [RGC] is up 22.74% over the past day.
Innodata, Inc. [INOD] is up 4.84% over the past day.
AeroVironment, Inc. [AVAV] is up 6.62% over the past day.